Edition:
United States

PLx Pharma Inc (PLXP.OQ)

PLXP.OQ on NASDAQ Stock Exchange Capital Market

6.85USD
23 Feb 2018
Change (% chg)

$0.15 (+2.24%)
Prev Close
$6.70
Open
$6.70
Day's High
$6.85
Day's Low
$6.70
Volume
597
Avg. Vol
4,664
52-wk High
$12.60
52-wk Low
$5.60

Chart for

About

PLx Pharma Inc., formerly Dipexium Pharmaceuticals, Inc., is a biopharmaceutical company. The Company is a late stage specialty pharmaceutical company focusing on commercializing its lead products: Aspertec 325 mg and Aspertec 81 mg (Aspertec). The Company’s products and technology includes PLxGuard delivery system, Aspertec 325... (more)

Overall

Beta: 1.54
Market Cap(Mil.): $59.31
Shares Outstanding(Mil.): 8.72
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 195.87 16.59
EPS (TTM): -- -- --
ROI: -- -0.71 35.07
ROE: -- -3.37 17.79

BRIEF-Park West Asset Management reports 12.3 pct stake in PLx Pharma

* Park West Asset Management Llc reports 12.3 percent stake in PLx Pharma Inc ‍​as of November 20 - SEC filing

Nov 20 2017

BRIEF-PLx Pharma Inc. Reports third quarter 2017 results

* Q3 loss per share $0.44 Source text for Eikon: Further company coverage:

Nov 09 2017

Earnings vs. Estimates